Sahil Dhingra

Stock Analyst at RBC Capital

(1.98)
# 3,226
Out of 4,478 analysts
2
Total ratings
100%
Success rate
38.5%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sahil Dhingra

Ligand Pharmaceuticals
May 11, 2026
Reiterated: Buy
Price Target: $252$262
Current: $320.42
Upside: -18.23%